Research / Study

Clinical Research in ALS (CRiALS)

Institutional study · Recruiting

Official study sources

Institutional study

Last verified: 09-30-2026 · Emory ALS Center

Overview

Official title
Clinical Research in ALS (CRiALS)
Brief title
Clinical Research in ALS (CRiALS)
Registration type
Institutional study
NCT number
Not stated
Status
Recruiting
Study category
Observational, Genetic, Biomarker, Biospecimen
Sponsor / center
Emory University
Research center
Emory ALS Center
Collaborators
Not stated in the official study record.
Study type
Observational study
Phase
Not applicable / observational
Enrollment
Not stated in the official study record.
Start date
Not stated in the official study record.
Primary completion date
Not stated in the official study record.
Estimated / actual completion date
Not stated in the official study record.
Last source update
Not stated in the official study record.

What is being studied?

The Emory page describes CRiALS as non-experimental clinical research and lists blood sample, skin sample, and/or spinal fluid donation plus an information questionnaire.

Intervention(s)

Not stated in the official study record.

Who may be eligible?

This is a simplified summary. The official study team or research center determines eligibility.

Population / disease status
Diagnosed ALS, Blood relative, Healthy control
Diagnosis / conditions
Amyotrophic lateral sclerosis
Age
Not stated in the official study record. to Not stated in the official study record.
Disease duration
Not stated in the official study record.
Respiratory criteria
Not stated in the official study record.
ALSFRS-R criteria
Not stated in the official study record.
Genetic criteria
Not stated in the official study record.
Medication requirements
Not stated in the official study record.

Official center study description

The Emory page describes CRiALS as non-experimental clinical research and lists blood sample, skin sample, and/or spinal fluid donation plus an information questionnaire.

Genetics

Gene-specific study?
Not stated
Gene or variant
Other specified ALS gene
Genetic test required?
Not stated
Known carrier required?
Not stated
Confirmed pathogenic variant required?
Not stated
Presymptomatic carriers eligible?
Not stated
At-risk relative eligible?
Yes
Genetic test provided?
Not stated
Genetic counseling provided?
Not stated
Results returned / offered?
Not stated
Family history required?
Not stated

Study design

Randomized?
Not stated in the official study record.
Allocation
Not stated in the official study record.
Intervention model
Not stated in the official study record.
Masking
Not stated in the official study record.
Placebo
Not stated in the official study record.
Primary purpose
Not stated in the official study record.

Endpoints

Primary outcome measures

Not stated in the official study record.

Secondary outcome measures

Not stated in the official study record.

A biomarker outcome should not automatically be interpreted as a clinical outcome.

Locations

Emory ALS Center

Atlanta, Georgia, United States

Location status: Recruiting

Contact: Not stated in the official study record.

Contact

Central contact: Not stated in the official study record.